A Phase II Clinical Trial of an Aromatase Inhibitor for Postmenopausal Women with Lymphangioleiomyomatosis.

about

Cystic Lung Disease in Genetic Syndromes with Deficient Tumor Suppressor Gene Function.Recent advances in the management of lymphangioleiomyomatosis.Intracrine Regulation of Estrogen and Other Sex Steroid Levels in Endometrium and Non-gynecological Tissues; Pathology, Physiology, and Drug Discovery

P2860

Q47370738-4E0214AF-E532-4269-91FB-ED910131CD66 Q55483958-E36A5880-DF54-45F7-B697-078D40380978 Q57072939-EA8277C1-82C3-4BAA-B9DA-8A5DFB75318A

P2860

A Phase II Clinical Trial of an Aromatase Inhibitor for Postmenopausal Women with Lymphangioleiomyomatosis.

Item

http://www.wikidata.org/entity/Q38676246

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

A Phase II Clinical Trial of a ...... with Lymphangioleiomyomatosis.

@en

type

Item

label

A Phase II Clinical Trial of a ...... with Lymphangioleiomyomatosis.

@en

prefLabel

A Phase II Clinical Trial of a ...... with Lymphangioleiomyomatosis.

@en

P1476

A Phase II Clinical Trial of a ...... with Lymphangioleiomyomatosis

@en

P2093

Adrian Shifren

http://www.w3.org/2001/XMLSchema#string

Calvin Lu

http://www.w3.org/2001/XMLSchema#string

Charles D Burger

http://www.w3.org/2001/XMLSchema#string

George P Pappas

http://www.w3.org/2001/XMLSchema#string

Hye-Seung Lee

http://www.w3.org/2001/XMLSchema#string

Jeffrey P Krischer

http://www.w3.org/2001/XMLSchema#string

Jeffrey T Chapman

http://www.w3.org/2001/XMLSchema#string

Joseph Parambil

http://www.w3.org/2001/XMLSchema#string

Lisa R Young

http://www.w3.org/2001/XMLSchema#string

Srihari Veeraraghavan

http://www.w3.org/2001/XMLSchema#string

P2860

Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4)

Serum vascular endothelial growth factor-D prospectively distinguishes lymphangioleiomyomatosis from other diseases

Efficacy and safety of sirolimus in lymphangioleiomyomatosis.

VEGF-D promotes the metastatic spread of tumor cells via the lymphatics

The tuberous sclerosis complex

Everolimus in postmenopausal hormone-receptor-positive advanced breast cancer

Pulmonary lymphangioleiomyomatosis. A study of 69 patients. Groupe d'Etudes et de Recherche sur les Maladies "Orphelines" Pulmonaires (GERM"O"P).

High frequency of pulmonary lymphangioleiomyomatosis in women with tuberous sclerosis complex.

Mutational and radiographic analysis of pulmonary disease consistent with lymphangioleiomyomatosis and micronodular pneumocyte hyperplasia in women with tuberous sclerosis.

European Respiratory Society guidelines for the diagnosis and management of lymphangioleiomyomatosis.

P304

919-928

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1513/ANNALSATS.201610-824OC

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Elizabeth Kopras

Francis Mccormack

Daniel F Dilling

P577

2017-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28570161

http://www.w3.org/2001/XMLSchema#string

P921

phase II clinical trial

A Phase II Clinical Trial of an Aromatase Inhibitor for Postmenopausal Women with Lymphangioleiomyomatosis.

about

P2860

P2860

A Phase II Clinical Trial of an Aromatase Inhibitor for Postmenopausal Women with Lymphangioleiomyomatosis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921